See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2013_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 35,173,144 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 166,386 |
| 3 | remainder_Assets | 3,429,640 |
| 4 | LiabilitiesCurrent | 10,593,665 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,229,523 |
| 9 | ResearchAndDevelopmentExpense | 16,888,849 |
| 10 | remainder_Expenses | 580,174 |
| 11 | remainder_Revenues | 2,300,736 |
| 12 | remainder_NetIncome | -4,319,929 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 38,769,170 |
| 1 | Liabilities | 10,593,665 |
| 2 | Expenses | 25,698,546 |
| 3 | Revenues | 2,300,736 |
| 4 | StockholdersEquity | 28,175,505 |
| 5 | NetIncome | -27,717,739 |
| 6 | ComprehensiveNetIncome | -27,717,739 |
| 7 | BaseVar | 40,841,023 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.37 |
| 9 | EconomicCapitalRatio | 2.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
